|
FY2021
12 months to Dec 31, 2021
|
FY2020
4 months to Dec 31, 2020
|
|
|---|---|---|
| Cash flows from operating activities | ||
| Net income (loss) | ||
| Adjustments to reconcile net loss to net cash provided by (used in) operating activities: | ||
| General and administrative expenses paid through Note from Sponsor | ||
| Interest earned on securities held in Trust Account | ||
| Prepaid expenses | ||
| Accounts payable | ||
| Accrued expenses | ||
| Franchise tax payable | ||
| Depreciation, amortization and accretion expense | ||
| Amortization of debt issuance costs | ||
| Amortization of intangibles and below-market contracts | ||
| Bad debt expense | ||
| Return on investment in equity method investments | ||
| Equity in earnings of equity method investments | ||
| Total (gains) losses on derivatives, net | ||
| Net cash received in settlement of derivatives | ||
| Forgiveness of Paycheck Protection Loan | ||
| Stock-based compensation expense | ||
| Changes in operating assets and liabilities: | ||
| Accounts receivable | ||
| Inventory | ||
| Prepaid expenses and other current assets | ||
| Accounts payable - trade | ||
| Accrued and other liabilities | ||
| Other non-current assets | ||
| Other long-term liabilities | ||
| Net cash used in operating activities | ||
| Cash flows from investing activities | ||
| Cash deposited in Trust Account | ||
| Acquisition of Aria, net of cash acquired | ||
| Acquisition of assets and businesses, excluding Aria | ||
| Additions to property, plant and equipment | ||
| Purchases of biogas rights | ||
| Contributions to equity method investments | ||
| Return of investment in equity method investments | ||
| Net cash used in investing activities | ||
| Cash flows from financing activities | ||
| Proceeds from note payable to related party | ||
| Repayment of note payable to related party | ||
| Proceeds received from initial public offering, gross | ||
| Proceeds received from private placement | ||
| Offering costs paid | ||
| Borrowings on line of credit agreement | ||
| Repayments on line of credit agreement | ||
| Proceeds from long-term debt, net of issuance costs | ||
| Repayments of long-term debt | ||
| Proceeds from PPP Loan | ||
| Proceeds from reverse recapitalization and PIPE Financing | ||
| Capital contributions | ||
| Proceeds from exercise of warrants | ||
| Repurchase of Class A Common Stock | ||
| Taxes paid on net share settled stock-based compensation awards | ||
| Acquisition of nonredeemable noncontrolling interest | ||
| Net cash provided by financing activities | ||
| Net change in cash | ||
| Cash - beginning of the period | ||
| Cash - end of the period | ||
| Offering costs paid by Sponsor in exchange for issuance of Class A and Class B common stock | ||
| Non-controlling interest in subsidiary | ||
| Offering costs included in accounts payable | ||
| Offering costs included in accrued expenses | ||
| Offering costs funded with note payable - related party | ||
| Deferred legal fees | ||
| Deferred underwriting commissions | ||
| Value of Class A ordinary shares subject to possible redemption | ||
| Net increase (decrease) in cash, cash equivalents and restricted cash | ||
| Cash, cash equivalents and restricted cash - beginning of period | ||
| Cash, cash equivalents and restricted cash - end of period | ||
| Supplemental cash flow information | ||
| Cash paid for interest | ||
| Non-cash investing activities | ||
| Accruals of property, plant and equipment and biogas rights incurred but not paid |
Loading...
